GI Cancer Session
Dr. Ritu Khare is a gastrointestinal surgeon practicing in the UAE since the last 12 years. She has done her Masters in General Surgery from King Edward Memorial Hospital in Mumbai, India followed by a specialization in Gastrointestinal Surgery from the Sanjay Gandhi Postgraduate Medical Institute at Lucknow, India. She is a member of the Royal College of Surgeons of Edinburgh. She has a vast experience in laparoscopic abdominal surgery having trained at the Institute of Laparoscopic Surgery at Bordeaux, France. She was the general secretary of the Emirates Society of Laparoendoscopic Surgeons in 2012-2013. She was commended for “Young Surgeon of the Year Award” at the Arab Health Congress, 2012. She is currently associated with the Medeor Group of Hospitals in Dubai and Abu Dhabi.
Completed Post graduate degree in Nuclear Medicine in 2003. Did residency at Tata memorial Hospital from 2005 -2009 and then joined as faculty at Tata memorial Hospital. Have done a short fellowship in PET/CT at Mallinckrodt institute of radiology, St Louis, USA .

Associated with reporting both general nuclear medicine scans and PET/CT using FDG. Associated with development of individualized protocols for indications of use of FDG PET/CT in multiple malignancies especially peadiatric. Also have experience of reading Ga 68 PSMA scans. Associated with radionuclide therapy for thyroid, NET, breast cancer and bone pain palliation. Co PI for initiating radionuclide therapy for Her 2 positive breast cancer patients.

Academically hold an Associate Professor position offering teaching and guidance for thesis of MD students of nuclear medicine. Also a thesis guide for students of nuclear medicine technology working towards their doctoral degree at other institutes. Have been reviewer for many national and few international peer reviewed oncology journals. Have guided residents for writing articles in many nuclear medicine journals.

Have been a part of organizing 2 International Atomic Energy Association (IAEA) workshops on Nuclear medicine in Oncology and therapy held in India and also as local national faculty for the same.
Faculty for national Nuclear Medicine and Oncological Congress and participated in international congress in Nuclear Medicine and Oncology.
-Prof and Surgical Oncologist & Director –Asian Cancer Institute- Mumbai,
-Bombay Hospital Professor Surgical Oncology M.Ch Teacher – Mumbai University, DNB Teacher, MCH & DNB examiner across India.
-Lilavati Hospital Honorary Surgical Oncologist & Professor.
-Principal investigator and co-investigator in multiple trials in Cancer Treatment in India and Abroad.
-Fellowship for training in Cancer at The Sloan Kettering Cancer Centre, New York, U.S.A. (Specialized training in Thoracic Oncology * Critical Care), 1982-1983
-Specialty in Thoracic Oncology & Breast Services at that Tata Memorial Hospital, Bombay, 1979-2003.
-Past Position:
i. Ex. Prof. & Surgeon, Head Dept. of Thoracic Oncology & Breast Services at the Tata Memorial Hospital, Bombay, 1985 till 1st September 2003.
-Fellowship to Memorial Sloan Kettering Cancer Centre, U.S.A 1982 in thoracic surgery critical care.
-Special Fellowship at Cornell University, New York, U.S.A. (Specialised in Oesophageal Cancer Surgery) Dr. David Skinner 1991.
-International Society of Diseases of “Oesophagus Fellowship for training in Oesophageal Cancer Surgery, Kurume University, Fakuoka, Japan (Oct.-Dec. 1991). Pioneer in starting 3 field esophagectomy in India.
-Training in Robotic Cancer Surgery, Jeweish Hospital Seattle, USA in Esophageal Surgery 2012.
-Fellow American College of Surgeons.
-Fellow International College of Surgeons, Chicago, U.S.A.
-Past President of Indian Society of Oncology, IASO.
-Current President – Indian Breast Group.
-Over 100 Publication in National and International PEER reviewed journals on varied subjects from Breast Cancer to Esophageal Cancer, Lung Cancer, Stenting, Laser, Endo- bronchial surgery.
-Written Book on “Breast Cancer Management” published by BCFI 2013.
Shailesh V. Shrikhande is Professor of Surgery and Head of GI and HPB Surgical Service at the Tata Memorial Center in Mumbai, India. He was ranked first in the Master of Surgery examinations of Mumbai University in 1997 and later received specialist training in Pancreatic Research and Pancreatic Surgery at the University of Bern, Switzerland and the University of Heidelberg, Germany. He was the first Asian to be awarded the Kenneth Warren Fellowship of the International Hepato-Pancreato-Biliary Association (IHPBA) in 2005. He was awarded the title of Doctor of Medicine by the University of Heidelberg for his original clinical and basic research on chronic pancreatitis and pancreatic cancer in 2006. He has been invited for over 350 lectures and orations all over India and other parts of the world. Apart from having published over 150 clinical and basic science research papers in leading peer reviewed journals (including a series of 500 Whipple Resections), Professor Shrikhande has also given live operative teaching demonstrations on pancreatic, gastric, gall bladder and colorectal cancer. In addition, he has contributed over 50 book chapters and is the Chief Editor of the book “Surgery of Pancreatic tumors” (2007) and “Pancreatic Cancer: Current Understanding” (2011) and ‘Modern Gastrointestinal Oncology (2015). To promote awareness on pancreatic tumors in Asia, he founded the website both for professionals and lay people. He is the Chief Editor of Indian Journal of Colorectal Diseases and Associate Editor, Langenbecks Archives of Surgery. He is the Chairman of the Indian Council Medical Research (ICMR) committee for developing guidelines for management of Gastric Cancer in India. He is also on editorial boards of many international journals dealing with GI and HPB surgery. He is the Chairman of the Scientific Committee of Indian Chapter of IHPBA. He is the Vice Chairman of the Scientific Committee of the International Hepato-Pancreato-Biliary Association and Member-at-Large of the Asia Pacific Hepato-Pancreato-Biliary Association. In recognition of his work on pancreatic cancer and digestive cancer surgery in India, he was awarded Honorary Fellowship of the Royal College of Surgeons of England in 2014 (FRCS – Ad Eundem).

Dr Ramesh Singh Bhandari is a consultant Hepato Pancreatic Biliary Liver Transplant and Gastrointestinal Surgeon working in capacity of Associate Professor of Surgery in Department of Surgery, Tribhuvan University Teaching Hospital, Kathmandu, Nepal. Dr Bhandari completed his MS General Surgery and MCh Surgical Gastroenterology from Institute of Medicine, Tribhuvan University, Nepal. In 2009, Dr Bhandari was awarded prestigious Rowan Nicks Scholarship from Royal Australasian College of Surgeon to undergo one-year fellowship in Hepato Biliary Pancreatic Surgery in Melbourne. For his interest in developing liver transplant program in Nepal, Dr Bhandari then completed one more year of Hepato biliary pancreatic and Liver Transplant fellowship from Austin, Melbourne. Since his return, Dr Bhandari has been working tirelessly to develop HPB surgery in Nepal and subsequently develop liver transplant program in Nepal. Currently his major bulk of work includes Gastrointestinal Cancer surgery and all complex HPB surgeries including benign conditions. He has done significant publications both in National and International journals and has presented his work in large number of international scientific meetings. He has also been actively participating as a faculty of HPB and GI Surgery in various national and international scientific meeting.

Dr Hendrik-Tobias Arkenau is the founding Medical Director of Sarah Cannon Research Institute UK, and is currently serving as the Executive Medical Director for SCRI UK and Clinical Lead for the Hospital Corporation of America International Cancer Service Line.

Dr Arkenau has vast experience in Early Oncology Clinical Drug Development with a special interest in gastrointestinal cancer and melanoma. He received his medical degree in 2000 at the Medical School Hanover, Germany, and completed his internship and specialist training in oncology in 2007. As part of SCRI’s collaboration with University College London (UCL), Dr Arkenau is appointed as a Professorial Research Associate on UCLs faculty and he holds an Honorary Consultant post with UCL Hospitals.

Sarah Cannon Research Institute UK’s remit is to incorporate all aspects of modern drug development from clinical pharmacology, molecular profiling to early clinical trials. The unique operational set-up aims to incorporate oncology drug development into day-to-day clinical practice with the ultimate goal to improve patient care.

Since its inauguration in 2010, Dr Arkenau has built up a trial portfolio of >80 early clinical trials. As Chief- and Principal Investigator he is actively involved in protocol development, toxicity review, pharmacokinetic analysis, biomarker and strategic development of new anti-cancer drugs, including immunotherapies. Dr Arkenau works as part of a multidisciplinary team of more than 40 members comprising of research nurses, operations specialist, project/data manager, regulatory adviser, QA-manager and other oncology specialists.

Dr Arkenau is Fellow of the Royal College of Physicians, and member of The German Cancer Society, ASCO, AACR and ESMO. He has presented multiple talks on the latest research in Oncology and has been Invited Speaker at several national/international meetings. Dr Arkenau has published articles in international peer-reviewed journals (e.g. Lancet, J Clin Oncol, Clin Cancer Res, Annals of Oncologyand others) and serves as ‘Contributing Associate Editor-in-Chief’ of the World Journal of Gastroenterology and ‘Associate Editor’ of World Journal of Cancer Research.
Dr Sudeep Gupta, completed his MBBS, MD and DM from All India Institute of Medical Sciences, New Delhi, in the year 2000 and has been a faculty member in the Department of Medical Oncology at Tata Memorial Centre since then. He has been a prolific clinical researcher who is actively involved in planning, organizing, conducting and analyzing Phase I, II and III clinical trials and has been a Principal Investigator or Co-investigator in more than 100 trials. He takes special interest in breast and gynecological cancers and early drug development. His research areas have involved implementation science including access to medications, guideline development, testing concepts and technology in clinical trials, innovative therapeutic strategies, toxicity and quality-of-life studies, pharmacokinetics and translational studies involving next-generation sequencing technology. He has published more than 120 papers in peer reviewed journals.

Since 2013 he has been the Deputy Director of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) one of the premier cancer translational research centres in India. He is currently engaged in facilitating cross talk between various stakeholders in cancer research at the institutional and national level, including basic scientists, clinical researchers, computational biologists, physicists, engineers and others.
Dr. Chehal is an adjunct Assistant professor of Medicine, GMU, Ajman, UAE.
Dr. Chehal is a consultant of Medical Oncology/Hematology at Mafraq Hospital in Abu Dhabi, UAE.

He graduated from the college of Medicine at Baghdad University/Iraq. He did his Internal Medicine residency and his Hematology/Oncology fellowship at the American University of Beirut, Lebanon.

Dr. Chehal is a member of many national and international societies including ASCO, ESMO, EHA,….. He had an important role in Tumor registry in Lebanon in 2002.

Dr. Chehal acted as chairperson, moderators, and member of scientific committee in many local and international congresses.

Dr. Chehal has 27 published articles in peer reviewed international journals; he is the first author on 9 of them, in addition to 29 abstracts.

He joined Mafraq hospital in 2006. His main interests are Lung cancer, Breast Cancer, GI malignancies and Lymphoma.

Jay Mehta is a trained surgical pathologist with specialization in oncopathology. He post graduated from the renowned Tata memorial hospital, Mumbai. Currently he consults at SRL Diagnostics' Centre of Excellence in Histopathology at Mumbai. Besides Oncopathology in general, he has special interest in lymphomas, bone marrow pathology, GI tumors and soft tissue sarcomas. He is among a handful of people in India who practice diagnostic molecular pathology. His molecular pathology laboratory does a wide range of tests, including IgH & TCR gene rearrangement studies for lymphomas, assessment of various adult & Paediatric soft tissue sarcoma translocations & next generation sequencing analysis of EGFR for lung cancers, extended RAS RAF testing for colonic tumors & KIT resistance mutations.

Bhawna Sirohi
Head of GI Cancer Session
United Kingdom
Paleswan Joshi Lakhey
Ramesh Bhandari
View Profile
Sanjay Sharma
View Profile
Shailesh V. Shrikhande
View Profile